期刊文献+

胆囊癌中骨桥蛋白和MMP-9的表达及其意义 被引量:2

Expression of Osteopontin (OPN) and MMP-9 in Gallbladder Cancer and Its Clinical Significance
暂未订购
导出
摘要 目的了解胆囊癌组织中骨桥蛋白和MMP-9的表达及其意义。方法选择正常的胆囊组织10例、胆囊腺瘤组织10例和胆囊癌组织40例,运用免疫组织化学方法,检测OPN和MMP-9的表达水平,对OPN和MMP-9表达的相关性进行分析研究。结果胆囊癌组织中OPN和MMP-9的表达水平明显高于胆囊组织和胆囊腺瘤组织(P<0.05),其中在有转移的胆囊癌组织中OPN的表达水平明显高于没有转移的胆囊癌组织(P<0.05)。胆囊癌组织中OPN和MMP-9的表达具有一致性(P<0.05)。结论 OPN与MMP-9的表达情况与胆囊癌浸润、转移发生有密切的关系,本实验结果证实MMP-9和OPN均阳性表达时对胆囊癌转移及预后有重要的预测价值。 Objective To explore expression of osteopontin and MMP-9 in gallbladder cancer and its clinical significance. Methods The expression of osteopontin and MMP-9 was detected by immunohistochemical method in 40 cases of gallbladder cancer, 10 cases of normal gallbladder and 10 cases of gallbladder adenoma. The relationship between the expression of osteopontin and MMP-9 was analyzed. Results The positive expression rates of osteopontin and MMP-9 in gallbladder cancer tissues were significantly higher than that in normal gallbladder tissues and gallbladder adenoma tissues ( P 〈 0.05 ). The positive expression rates of osteopontin in patients of NEVIN IV, V stages were higher than that in patients of NEVIN I , II, m stages ) (P 〈 0.05 ). The expression of osteopontin was positively correlated with the expression of MMP-9 (P 〈 0.05 ). Conclusion Both osteopontin and MMP-9 are significantly related to the metastasis of gallbladder cancer, and overexpression of both osteopontin and MMP-9 has a predictive value for metastasis and recurrence.
出处 《中国现代医生》 2011年第31期61-62,70,共3页 China Modern Doctor
关键词 胆囊癌 肿瘤转移 骨桥蛋白 MMP-9 免疫组化 Gallbladder cancer Tumor metastasis Osteopontin MMP-9 Immunohistochemistry
  • 相关文献

参考文献6

二级参考文献39

  • 1张东涛,袁静,杨力,郭新宁,郝志明,韩者艺,吴开春,樊代明.骨桥蛋白在胃癌中的表达及与胃癌侵袭转移的关系[J].中华肿瘤杂志,2005,27(3):167-169. 被引量:18
  • 2魏少峰,郜玉峰,李旭,桂淑玉,汪渊,江晓平,李家斌.骨桥蛋白和P21在原发性肝癌中的表达及其临床意义[J].实用肝脏病杂志,2005,8(2):73-76. 被引量:7
  • 3Rudland PS, Platt-Higgins A, E1-Tanani M, et al. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Cancer Res,2002,62:3417-3427.
  • 4Denhardt DT, Noda M, O'Regan AW, et al. Osteopantin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest,2001, 107: 1055-1061.
  • 5Ye QH, Qin LX, Forgues M,et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med,2003,9:416-423.
  • 6Zhang J, Takahashi K, Takahashi F, et al. Differential osteopantin expression in lung cancer. Cancer Letters,2001,171: 215-222.
  • 7Denhardt DT. Commentary re: Q-T Le et al, identification of osteopontin as a prognostic marker for head and neck squamous cell carcinomas. Clin Cancer Res,2003,9:31-32.
  • 8Denhardt DT, Mistretta D, Chambers AF, et al. Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter. Clin Exp Metastasis, 2003,20: 77-84.
  • 9Ue T, Yokozaki H, Kitadai Y, et al. Co-expression of osteopontin and CD44v9 in gastric cancer. Int J Cancer, 1998,79:127-132.
  • 10Nemoto H, Rittling SR, Yoshitake H, et al. Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues. J Bone Miner Res,2001,16:652-659.

共引文献25

同被引文献20

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部